Volatile organic compounds analysis optimization and biomarker discovery in urine of Non-Hodgkin lymphoma patients before and during chemotherapy

Página do item simplificado
dc.contributor.authorde Sousa Mesquita A.
dc.contributor.authorZamora-Obando H.R.
dc.contributor.authorNeves dos Santos F.
dc.contributor.authorSchmidt-Filho J.
dc.contributor.authorCordeiro de Lima V.
dc.contributor.authorD'Almeida Costa F.
dc.contributor.authorPiana de Andrade V.
dc.contributor.authorNogueira Eberlin M.
dc.contributor.authorColnaghi Simionato A.V.
dc.date.accessioned2024-03-12T23:45:51Z
dc.date.available2024-03-12T23:45:51Z
dc.date.issued2020
dc.description.abstract© 2020 Elsevier B.V.The Non-Hodgkin's lymphoma (NHL) is a severe and common neoplasm generated by metabolic changes due to cells mutations. Its prognostic or diagnosis seems therefore viable by monitoring metabolites produced and secreted into biological fluids or tissues. Hence, we used an untargeted metabolomics approach to evaluate if the profiles of volatile organic compounds (VOCs) present in urine would serve to Non-Hodgkin's lymphoma (NHL) prognostic or diagnostic. Headspace solid-phase microextraction (HS-SPME) was optimized and applied to pools of urine or serum samples from healthy patients after optimization using a Central Composite Design (CCD), followed by gas chromatography coupled to mass spectrometry (GC–MS) analysis. CCD factorial design 23 and the response surfaces indicated the optimized extraction parameters. Individual urine samples from healthy and diseased subjects were prepared and analyzed by the optimized method, and a thorough statistical analysis revealed several metabolites as potential biomarkers for NHL as well as able to describe the patient's metabolic profile before each chemotherapy cycle. This approach seems promising in contributing to the prognosis and choice of appropriate treatment of NHL for each individual.
dc.description.volume159
dc.identifier.doi10.1016/j.microc.2020.105479
dc.identifier.urihttps://dspace.mackenzie.br/handle/10899/34862
dc.relation.ispartofMicrochemical Journal
dc.rightsAcesso Restrito
dc.subject.otherlanguageBiomarkers
dc.subject.otherlanguageCentral composite design
dc.subject.otherlanguageGC–MS
dc.subject.otherlanguageHS-SPME
dc.subject.otherlanguageNon-hodgkin lymphoma
dc.subject.otherlanguageVolatile organic compounds
dc.titleVolatile organic compounds analysis optimization and biomarker discovery in urine of Non-Hodgkin lymphoma patients before and during chemotherapy
dc.typeArtigo
local.scopus.citations9
local.scopus.eid2-s2.0-85091746719
local.scopus.updated2024-05-01
local.scopus.urlhttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85091746719&origin=inward
Arquivos
Coleções
Artigos de periódico